Rep. Robert Bresnahan, Jr. Sells Off Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Representative Robert Bresnahan, Jr. (R-Pennsylvania) recently sold shares of UnitedHealth Group Incorporated NYSE: UNH. In a filing disclosed on March 27th, the Representative disclosed that they had sold between $15,001 and $50,000 in UnitedHealth Group stock on February 25th.

Representative Robert Bresnahan, Jr. also recently made the following trade(s):

• Purchased $1,001 - $15,000 in shares of Intuit NASDAQ: INTU on 3/7/2025.
• Sold $1,001 - $15,000 in shares of Tesla NASDAQ: TSLA on 3/6/2025.
• Purchased $1,001 - $15,000 in shares of SEA NYSE: SE on 3/5/2025.
• Sold $1,001 - $15,000 in shares of Credo Technology Group NASDAQ: CRDO on 3/4/2025.
• Purchased $1,001 - $15,000 in shares of Meta Platforms NASDAQ: META on 3/4/2025.
• Purchased $1,001 - $15,000 in shares of Twilio NYSE: TWLO on 3/4/2025.
• Sold $15,001 - $50,000 in shares of Alibaba Group NYSE: BABA on 3/4/2025.
• Purchased $1,001 - $15,000 in shares of Zoom Video Communications NASDAQ: ZM on 3/4/2025.
• Purchased $1,001 - $15,000 in shares of Intel NASDAQ: INTC on 3/3/2025.
• Purchased $1,001 - $15,000 in shares of Snowflake NYSE: SNOW on 3/3/2025.

UnitedHealth Group Stock Performance

UNH traded up $2.17 during midday trading on Tuesday, hitting $525.92. 1,072,060 shares of the company traded hands, compared to its average volume of 4,260,509. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company's 50-day moving average is $509.10 and its 200 day moving average is $543.47. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The firm has a market capitalization of $481.07 billion, a PE ratio of 33.93, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business's quarterly revenue was up 6.8% compared to the same quarter last year. During the same period in the previous year, the company posted $5.83 EPS. On average, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.60%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's payout ratio is 54.19%.

Institutional Trading of UnitedHealth Group

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Mascagni Wealth Management Inc. acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth approximately $66,000. Fairtree Asset Management Pty Ltd purchased a new position in UnitedHealth Group during the fourth quarter worth about $1,333,000. DSG Capital Advisors LLC purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at approximately $25,606,000. Chancellor Financial Group WB LP purchased a new stake in shares of UnitedHealth Group during the 4th quarter valued at approximately $2,169,000. Finally, Triton Wealth Management PLLC grew its position in UnitedHealth Group by 8.8% in the fourth quarter. Triton Wealth Management PLLC now owns 493 shares of the healthcare conglomerate's stock worth $249,000 after acquiring an additional 40 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.

Insider Activity

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the company's stock in a transaction on Friday, January 17th. The stock was bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now directly owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.33% of the company's stock.

Analyst Ratings Changes

A number of equities analysts recently commented on UNH shares. Cantor Fitzgerald reissued an "overweight" rating and set a $700.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. Stephens increased their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an "overweight" rating in a research report on Thursday, December 5th. StockNews.com upgraded UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Thursday, January 23rd. Oppenheimer raised their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the company an "outperform" rating in a research note on Friday, December 6th. Finally, Piper Sandler lowered their price target on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a research report on Thursday, January 2nd. Twenty investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Buy" and a consensus target price of $629.32.

About Representative Bresnahan

Rob Bresnahan Jr. (Republican Party) is a member of the U.S. House, representing Pennsylvania's 8th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Bresnahan (Republican Party) is running for re-election to the U.S. House to represent Pennsylvania's 8th Congressional District. He declared candidacy for the 2026 election. Rob Bresnahan Jr. was born in Kingston, Pennsylvania. He earned a B.S. in business administration, management and operations from the University of Scranton in 2012. His career experience includes working as the chief financial officer and CEO of a family business, an electrical contracting company.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.